CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Ref. TM-TMPK-00184
| 1mg | 5,163.00 € | ||
| 100µg | 798.00 € | ||
| 500µg | 3,085.00 € |
Product Information
- MS4A-1, CD20, B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 11, Leukocyte surface antigen Leu-16, Bp35, MS4A1
B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases. CD20 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in E. coli expression system with C-His-Avi tag. The predicted molecular weight is 16.8 kDa and the accession number is P11836-1.
Chemical properties
Technical inquiry about: TM-TMPK-00184 CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
